News

Patients in the study are randomized on a 2:1 basis in favor of Xiaflex treatment. To qualify for the study, patients must have at least 20 degrees of

Despite the acceptance, the company continues to believe that its ANDA as originally filed met all the requirements for acceptance and thus will continue to pursue its administrative

In the study, treatment with the nanobody did not result in detectable immunogenicity. The study suggests that ALX-0081 adopts at least the plasma half-life of the target, von

In this study of 49 patients, the combination of Tykerb plus capecitabine (Xeloda) showed a reduction in HER2-positive breast cancer that had spread to the brain and had

In the international Acclaim trial, Celacade was shown to significantly reduce the risk of death or cardiovascular hospitalizations in large pre-specified subgroups of patients with chronic heart failure,

Under the terms of the agreement, Quest Pharma has already received $1,000,000; and the balance of $2,000,000 will be paid within the next twelve months. In return for

This agreement is said to make Siemens Medical Solutions Diagnostics the first in vitro diagnostics distributor of an automated TSH receptor antibody (TRAb) assay featuring stimulating TRAb KreLo

The data from the analysis of 61 patients demonstrated that Rapinyl met its primary endpoint, the sum of pain intensity difference from baseline to 30 minutes (SPID 0-30),

Each unit consists of one common share and one-half of one common share purchase warrant. Each whole warrant entitles its holder to acquire one additional common share for